You Position: Home > Paper
Antiviral treatment for hepatitis B: progress and challenges
( views:282, downloads:104 )
- Author:
- No author available
- Journal Title:
- CHINESE JOURNAL OF CLINICAL INFECTIOUS DISEASES
- Issue:
- 2
- DOI:
- 10.3760/cma.j.issn.1674-2397.2010.02.001
- Key Word:
- 肝炎,乙型;抗病毒治疗;Hepatitis B;Antiviral treatment
Abstract： @@ HBV感染呈全球性分布,其中亚洲和非洲的发展中国家为高发地区.全球HBV感染者约4亿.我国自1992年起将全国新生儿接种乙型肝炎疫苗纳入计划免疫后,HBsAg阳性率已由1992年的9.75%降至2006年的7.18%.然而,我国慢性乙型肝炎患者仍有2000万左右,是我国肝硬化和肝细胞性肝癌(HCC)的主要病因,是国家重点防治的传染病之一.
- [1]中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南[J].2005,(6).
- [2]European Association for the Study of the Liver.EASL Clinical Practice Guidelines: Management of chronic hepatitis B[J].2009,50(2).
- [3]Esteban-Mur R,Koff RS,Gane EJ,etc.Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B.[J].2007,5(8).
- [4]Lok AS,McMahon BJ.Chronic hepatitis B: update 2009.[J].2009,50(3).